trending Market Intelligence /marketintelligence/en/news-insights/trending/3uK4fbLh1ozSTc99J5ocEQ2 content esgSubNav
In This List

Biocartis raises €80M via equity placement

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Biocartis raises €80M via equity placement

Biocartis Group NV raised about €80 million in gross proceeds through a private placement via an accelerated bookbuild offering of 6.4 million new shares.

The company offered the shares, representing about 14.33% of its outstanding stock, at 12.50 apiece.

Biocartis plans to use the net proceeds to fund the expansion of Idylla test menu and applications, its sales and marketing activities and the ongoing increase of its cartridge manufacturing capacity. It also intends to use the funds for working capital and other general corporate purposes.

The payment and delivery of the shares is expected to take place on Dec. 1 and an application will be made to admit the new shares to trading on the regulated market of Euronext Brussels at the same time.

J.P. Morgan, Degroof Petercam, KBC Securities and Kempen acted as joint book runners in the offering.